Introduction: Serum soluble CD30 (sCD30), a 120-kD glycoprotein that belongs to the tumor necrosis factor receptor family, has been suggested as a marker of rejection in kidney transplant patients. The aim of this study was to evaluate the relationship between sCD30 levels and anti-HLA antibodies, and to compare sCD30 levels in patients undergoing hemodialysis (HD) with and without failed renal allografts and transplant recipients with functioning grafts
We evaluated aspects of the pathogenesis, diagnosis, and prognosis of antibody-mediated injury secon...
The most common cause of graft failure in kidney transplant recipients, apart from death with a func...
BACKGROUND: Renal transplantation is currently the prevalent therapy for most patients with end-stag...
WOS: 000394162200001PubMed ID: 28058698Introduction: Serum soluble CD30 (sCD30), a 120-kD glycoprote...
The purpose of this study was to evaluate the association of post-transplant soluble CD30 (sCD30) le...
Several studies have shown association of high pre- or post-transplant levels of soluble CD30 (sCD30...
High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feas...
BACKGROUND: Serum soluble CD30 (sCD30) levels might be a useful marker of immunologic status in pre ...
Item does not contain fulltextBACKGROUND: Previous reports revealed the potential value of the solub...
In a previous study, we have shown that HLA class II antibodies and a high soluble CD30 (sCD30) meas...
Analysing the relevance of soluble CD30 (sCD30) in the bloodstream before and after transplantation ...
OBJECTIVES: To retrospectively compare the accuracy of pretransplant panel of reactivity antibod...
OBJECTIVES: To retrospectively compare the accuracy of pretransplant panel of reactivity antibod...
BACKGROUND AND OBJECTIVE: Various abnormalities of the immune system have been demonstrated in patie...
Background: Soluble CD30 (sCD30) has been associated with rejection and graft loss in kidney transpl...
We evaluated aspects of the pathogenesis, diagnosis, and prognosis of antibody-mediated injury secon...
The most common cause of graft failure in kidney transplant recipients, apart from death with a func...
BACKGROUND: Renal transplantation is currently the prevalent therapy for most patients with end-stag...
WOS: 000394162200001PubMed ID: 28058698Introduction: Serum soluble CD30 (sCD30), a 120-kD glycoprote...
The purpose of this study was to evaluate the association of post-transplant soluble CD30 (sCD30) le...
Several studies have shown association of high pre- or post-transplant levels of soluble CD30 (sCD30...
High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feas...
BACKGROUND: Serum soluble CD30 (sCD30) levels might be a useful marker of immunologic status in pre ...
Item does not contain fulltextBACKGROUND: Previous reports revealed the potential value of the solub...
In a previous study, we have shown that HLA class II antibodies and a high soluble CD30 (sCD30) meas...
Analysing the relevance of soluble CD30 (sCD30) in the bloodstream before and after transplantation ...
OBJECTIVES: To retrospectively compare the accuracy of pretransplant panel of reactivity antibod...
OBJECTIVES: To retrospectively compare the accuracy of pretransplant panel of reactivity antibod...
BACKGROUND AND OBJECTIVE: Various abnormalities of the immune system have been demonstrated in patie...
Background: Soluble CD30 (sCD30) has been associated with rejection and graft loss in kidney transpl...
We evaluated aspects of the pathogenesis, diagnosis, and prognosis of antibody-mediated injury secon...
The most common cause of graft failure in kidney transplant recipients, apart from death with a func...
BACKGROUND: Renal transplantation is currently the prevalent therapy for most patients with end-stag...